IFNA1 and renal cell carcinoma: One of the integral molecules of the IFN receptor signaling is STAT3 (8) and a SNP in STAT3 (i.e., rs4796793) has been reported to be associated with response to IFNα therapy in renal cell carcinoma patients (7).